RECRUITING

Alcohol Labeling Study

Conditions

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This study aims to examine the effects of new front-of-package alcohol warnings on alcohol consumption. Participants will be randomly assigned to either new front-of-package health warnings or control labels. Participants will bring in their own alcohol to weekly study visits and take home the alcohol to consume as usual. Participants will receive study labels on their alcohol containers per their assigned trial arm.

Official Title

Alcohol Labeling Study

Quick Facts

Study Start:2025-04-28
Study Completion:2027-04
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06835920

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:21 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Adults ages 21 years and older
  2. * Not identified as having possible alcohol dependence
  3. * Consumed alcohol at least once per week during the past 4 weeks
  4. * At least half of alcohol consumed each week is from store-bought containers
  5. * Willing to bring 8 days' worth of alcohol to 3 in-person study visits
  6. * Not pregnant, breastfeeding, or trying to get pregnant
  7. * Able to take surveys in English
  8. * Willing to respond to text messages daily for 3 weeks
  9. * Not living in the same household as anyone else in the study
  1. Pregnancy or breastfeeding
  2. Severe psychiatric disorders
  3. Active substance abuse
  4. Unstable medical conditions
  5. Inability to comply with study requirements

Contacts and Locations

Principal Investigator

Marissa Hall, PhD
PRINCIPAL_INVESTIGATOR
University of North Carolina, Chapel Hill

Study Locations (Sites)

UNC study office
Chapel Hill, North Carolina, 27599
United States
University of North Carolina
Chapel Hill, North Carolina, 27599
United States

Collaborators and Investigators

Sponsor: University of North Carolina, Chapel Hill

  • Marissa Hall, PhD, PRINCIPAL_INVESTIGATOR, University of North Carolina, Chapel Hill

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-04-28
Study Completion Date2027-04

Study Record Updates

Study Start Date2025-04-28
Study Completion Date2027-04

Terms related to this study

Additional Relevant MeSH Terms

  • Health Behavior